{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:10:16Z","timestamp":1790435416353,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejca.2015.06.002","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T10:03:26Z","timestamp":1435831406000},"page":"1822-1830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimens"],"prefix":"10.1016","volume":"51","clinical-trial-number":[{"clinical-trial-number":"nct02070432","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Luis B.","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edgia C.","family":"Gomes-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz M.","family":"D\u0105browski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.","family":"Arnaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2015.06.002_b0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2015.06.002_b0010","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1088\/0022-3727\/38\/15\/004","article-title":"Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000nm","volume":"38","author":"Bashkatov","year":"2005","journal-title":"J Phys D Appl Phys"},{"key":"10.1016\/j.ejca.2015.06.002_b0015","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1039\/c3pp25419d","article-title":"The challenging combination of intense fluorescence and high singlet oxygen quantum yield in photostable chlorins \u2013 a contribution to theranostics","volume":"12","author":"Silva","year":"2013","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.ejca.2015.06.002_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-385904-4.00006-8","article-title":"Design of porphyrin-based photosensitizers","volume":"63","author":"Arnaut","year":"2011","journal-title":"Adv Inorg Chem"},{"key":"10.1016\/j.ejca.2015.06.002_b0025","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1039\/c0pp00315h","article-title":"Antitumor immunity promoted by vascular occluding therapy: Lessons from vascular-targeted photodynamic therapy (VTP)","volume":"10","author":"Preise","year":"2011","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.ejca.2015.06.002_b0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.freeradbiomed.2014.05.003","article-title":"The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy (PDT)","volume":"73","author":"Krzykawska-Serda","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ejca.2015.06.002_b0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1572-1000(05)00007-4","article-title":"Mechanisms in photodynamic therapy: Part one \u2013 photosensitisers, photochemistry and cellular localization","volume":"1","author":"Castano","year":"2004","journal-title":"Photodiagn Photodyn Ther"},{"key":"10.1016\/j.ejca.2015.06.002_b0040","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.ejca.2011.06.031","article-title":"New insights of mitochondria reactive species generation and cell apoptosis induced by low dose photodynamic therapy","volume":"47","author":"Zhao","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc1894","article-title":"Photodynamic therapy and anti-tumour immunity","volume":"6","author":"Castano","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0050","first-page":"1698","article-title":"Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma","volume":"110","author":"Peng","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2015.06.002_b0055","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/bjc.1997.502","article-title":"Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval","volume":"76","author":"Andrejevic-Blant","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/00912700222011607","article-title":"Clinical pharmacokinetics of verteporfin","volume":"42","author":"Houle","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ejca.2015.06.002_b0065","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/bjc.2014.95","article-title":"Phase I\/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer","volume":"110","author":"Huggett","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0070","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1158\/0008-5472.CAN-07-1778","article-title":"Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils","volume":"67","author":"Kousis","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2015.06.002_b0075","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1002\/chem.201304202","article-title":"Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers","volume":"20","author":"Arnaut","year":"2014","journal-title":"Chem Eur J"},{"key":"10.1016\/j.ejca.2015.06.002_b0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cmdc.201300449","article-title":"Modulation of biodistribution, pharmacokinetics and photosensitivity with the delivery vehicle of a bacteriochlorin photosensitizer for photodynamic therapy","volume":"9","author":"Saavedra","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejca.2015.06.002_b0085","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/S0959-8049(12)71441-7","article-title":"Non-invasive prognostic tools for phototherapeutic response in murine tumors","volume":"48","author":"Krzykawska","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0090","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0406242101","article-title":"Bacteriolytic therapy can generate a potent immune response against experimental tumors","volume":"101","author":"Agrawal","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2015.06.002_b0095","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1751-1097.1987.tb04856.x","article-title":"Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response","volume":"46","author":"Fingar","year":"1987","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.ejca.2015.06.002_b0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis","volume":"105","author":"Gooden","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00262-008-0527-0","article-title":"Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humural immunity","volume":"58","author":"Preise","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ejca.2015.06.002_b0110","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ejca.2014.01.017","article-title":"5-Aza-20-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy","volume":"50","author":"Wachowska","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0115","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.bjc.6603792","article-title":"CD8+ T cell-mediated control of distant tumours following local photodynamic therapy in independent of CD4+ T cells and dependent on natural killer cells","volume":"96","author":"Kabingu","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0120","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/ijc.23248","article-title":"Acute phase response induction by cancer treatment with photodynamic therapy","volume":"122","author":"Korbelik","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ijc.10299","article-title":"Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-Bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery","volume":"99","author":"Schreiber","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015194","article-title":"Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response","volume":"5","author":"Mroz","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2015.06.002_b0135","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/bjc.2013.580","article-title":"Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen","volume":"109","author":"Reginato","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0140","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1158\/0008-5472.CAN-03-3513","article-title":"Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors","volume":"64","author":"Henderson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2015.06.002_b0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1117\/12.44053","article-title":"Dependence of photodynamic threshold dose on treatment parameters in normal rat liver in vivo","volume":"1426","author":"Farrel","year":"1991","journal-title":"Proc SPIE"},{"key":"10.1016\/j.ejca.2015.06.002_b0150","first-page":"7986","article-title":"In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy","volume":"63","author":"Niedre","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2015.06.002_b0155","unstructured":"AAPM, Photodynamic Therapy Dosimetry. American Association of Physicists in Medicine, 2005."},{"key":"10.1016\/j.ejca.2015.06.002_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bjc.1987.147","article-title":"The effect of localized porphyrin photodynamic therapy on the induction of tumor metastasis","volume":"56","author":"Gomer","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.06.002_b0165","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1073\/pnas.0709256105","article-title":"Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model","volume":"105","author":"Castano","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2015.06.002_b0170","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1158\/0008-5472.CAN-11-2572","article-title":"Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer\/testis antigen P1A","volume":"73","author":"Mroz","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2015.06.002_b0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1667\/0033-7587(2002)158[0339:EOIFRO]2.0.CO;2","article-title":"Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografs in nude mice","volume":"158","author":"Coutier","year":"2002","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejca.2015.06.002_b0180","first-page":"7236","article-title":"Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas","volume":"50","author":"Gibson","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2015.06.002_b0185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/lsm.20327","article-title":"Fluence rate as a modulator of PDT mechanisms","volume":"38","author":"Henderson","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ejca.2015.06.002_b0190","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1039\/b9pp00004f","article-title":"Fluence-rate dependent intramolecular heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy","volume":"8","author":"Busch","year":"2009","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.ejca.2015.06.002_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1751-1097.2007.00139.x","article-title":"Effect of photosensitizer dose on fluence rate responses to photodynamic therapy","volume":"83","author":"Wang","year":"2007","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.ejca.2015.06.002_b0200","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1667\/RR2075.1","article-title":"Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate","volume":"174","author":"Busch","year":"2010","journal-title":"Radiat Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915004967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915004967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T02:29:06Z","timestamp":1537496946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915004967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":40,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0959804915004967"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.06.002","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimens","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}